When to Use Surgery & Radiation to the Breast - Metastatic Breast Cancer Trial Talk

Research News

Headlines announcing the phase III clinical trial (ECOG-ACRIN 2108) results stated that radiation and surgery to the breast–also called locoregional therapy (LRT)– for people with de novo metastatic breast cancer did not increase survival. Yet, doctors still decide on a case-by-case basis when to use LRT because there are still questions about when LRT might increase survival

See below for links discussing the trial, remaining research questions, and other reasons someone might choose LRT.

Last Modified on March 26, 2021



for past articles or specific information.